• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial.

作者信息

Segelov Eva, Prenen Hans, Day Daphne, Macintyre C Raina, Foo Estelle Mei Jye, Ali Raghib, Wang Quanyi, Wei Xiaoting, Lopes Gilberto de Lima, Ding Kefeng, Chen Gong, Chia John Whay Kuang, Toh Han Chong

机构信息

Department of Oncology, Monash Health, and Faculty of Medicine, Monash University, Melbourne, Victoria, Australia.

Oncology Department, University Hospital Antwerp, Edegem, Belgium.

出版信息

JCO Glob Oncol. 2020 Apr;6:585-588. doi: 10.1200/GO.20.00072.

DOI:10.1200/GO.20.00072
PMID:32293940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7193776/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f6/7193776/2d05c4d6e1d7/GO.20.00072f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f6/7193776/2d05c4d6e1d7/GO.20.00072f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/30f6/7193776/2d05c4d6e1d7/GO.20.00072f1.jpg

相似文献

1
Impact of the COVID-19 Epidemic on a Pan-Asian Academic Oncology Clinical Trial.新冠疫情对泛亚学术肿瘤学临床试验的影响。
JCO Glob Oncol. 2020 Apr;6:585-588. doi: 10.1200/GO.20.00072.
2
Rethinking Clinical Trials Reform During the COVID-19 Pandemic.新冠疫情期间对临床试验改革的反思
JAMA Oncol. 2020 Sep 1;6(9):1327-1329. doi: 10.1001/jamaoncol.2020.3142.
3
Disruption of cancer care in Canada during COVID-19.新冠疫情期间加拿大癌症护理的中断情况。
Lancet Oncol. 2020 Aug;21(8):e374. doi: 10.1016/S1470-2045(20)30397-1. Epub 2020 Jul 23.
4
COVID-19 Pandemic and Its Effects on Cancer Care, Both Good and Bad.COVID-19 大流行及其对癌症治疗的双重影响（既有好的影响，也有坏的影响）。
Oncology (Williston Park). 2020 Jul 15;34(7):244.
5
Maintaining a Medical Oncology Service during the Covid-19 Pandemic.在新冠疫情期间维持肿瘤内科服务。
Ir Med J. 2020 May 7;113(5):77.
6
Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak.2019冠状病毒病（COVID-19）疫情期间口腔癌的继续医学教育
Oral Oncol. 2020 Jun;105:104713. doi: 10.1016/j.oraloncology.2020.104713. Epub 2020 Apr 16.
7
COVID-19 and readjusting clinical trials.2019冠状病毒病与临床试验的重新调整
Lancet. 2020 Aug 22;396(10250):523-524. doi: 10.1016/S0140-6736(20)31787-6.
8
Editorial: Clinical trial design in the era of COVID-19.社论：新冠疫情时代的临床试验设计
Clin Trials. 2020 Oct;17(5):465-466. doi: 10.1177/1740774520940230. Epub 2020 Jul 10.
9
Oncology Clinical Trials During the COVID-19 Pandemic.肿瘤学临床试验在 COVID-19 大流行期间。
Oncology (Williston Park). 2020 Jul 15;34(7):265-269.
10
Telemedicine Use in Oncology Practices.肿瘤学实践中的远程医疗应用。
Oncology (Williston Park). 2020 Jul 15;34(7):280-282.

引用本文的文献

1
Operational Challenges of an Asia-Pacific Academic Oncology Clinical Trial.亚太地区肿瘤学临床研究的实施挑战
JCO Glob Oncol. 2023 Jun;9:e2300040. doi: 10.1200/GO.23.00040.
2
The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration.反对在癌症临床试验中对无进展生存期进行 censoring 的案例——以大流行封锁为例。
BMC Med Res Methodol. 2022 Oct 5;22(1):260. doi: 10.1186/s12874-022-01731-5.
3
The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.

本文引用的文献

1
Scientists fear coronavirus spread in countries least able to contain it.科学家担心冠状病毒在最无力控制疫情的国家蔓延。
Nature. 2020 Feb;578(7795):348. doi: 10.1038/d41586-020-00405-w.
2
COVID-19: what is next for public health?新冠疫情：公共卫生的下一步走向何方？
Lancet. 2020 Feb 22;395(10224):542-545. doi: 10.1016/S0140-6736(20)30374-3. Epub 2020 Feb 13.
3
A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment.一种在中国出现的新型冠状病毒——影响评估的关键问题
2019年冠状病毒病对国家临床试验网络乳腺癌试验的影响
Curr Breast Cancer Rep. 2021;13(3):103-109. doi: 10.1007/s12609-021-00417-z. Epub 2021 May 12.
4
Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.克服 COVID-19 大流行对亚洲肿瘤早期阶段试验和药物开发的影响——亚洲肿瘤早期阶段 1 联盟的经验和观点。
Asia Pac J Clin Oncol. 2021 Aug;17(4):388-395. doi: 10.1111/ajco.13510. Epub 2021 Jan 27.
5
Cancerona: Challenges of Cancer Management in Times of COVID-19 Pandemic.《癌症在新冠疫情时代：癌症管理面临的挑战》
SN Compr Clin Med. 2020;2(11):2005-2014. doi: 10.1007/s42399-020-00549-w. Epub 2020 Sep 30.
6
Minimizing transmission of COVID-19 while delivering optimal cancer care in a National Cancer Centre.在国家癌症中心提供最佳癌症护理的同时，尽量减少新冠病毒的传播。
J Cancer Policy. 2020 Sep;25:100241. doi: 10.1016/j.jcpo.2020.100241. Epub 2020 Jul 9.
7
Dual Challenge of Cancer and COVID-19: Impact on Health Care and Socioeconomic Systems in Asia Pacific.癌症与新冠疫情的双重挑战：对亚太地区医疗保健及社会经济体系的影响
JCO Glob Oncol. 2020 Jun;6:906-912. doi: 10.1200/GO.20.00227.
N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.